A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Mortality of patients with COPD participating in chronic disease management programmes: a happy end?
Concerns about increased mortality could question the role of COPD chronic disease management (CDM) programmes. We aimed at extending a recent Cochrane review to assess the effects of CDM on mortality in patients with COPD. Methods Mortality data were available for 25 out of 29 trials identified in a COPD integrated care systematic review. Metaanalysis using random-effects models was performed, followed by subgroup analyses according to study length (3-12 months vs >12 months), maindoi:10.1136/thoraxjnl-2013-204983 pmid:24718640 fatcat:2txtlqjqhjf4vgul5c4bftnrce